Editing Nephrology clinical (TRPM7)

{{tp|p=26487689|t=2015. Magnesium Modifies the Impact of Calcitriol Treatment on Vascular Calcification in Experimental Chronic Kidney Disease.|pdf=|usr=}}{{26487689}}
{{tp|p=32047249|t=2020. TRPM7 contributes to progressive nephropathy.|pdf=|usr=}}{{32047249}}
{{tp|p=38093238|t=2023. Serum magnesium level and cardiac valve calcification in hemodialysis patients.|pdf=|usr=}}{{38093238}}
{{tp|p=37582785|t=2023. The relationship between coronary artery calcification and bone metabolic markers in maintenance hemodialysis patients.|pdf=|usr=}}{{37582785}}
{{tp|p=35656113|t=2022. Vascular Calcification in Chronic Kidney Disease: An Update and Perspective.|pdf=|usr=}}{{35656113}}
{{tp|p=33917965|t=2021. Vascular Calcification in Chronic Kidney Disease: Diversity in the Vessel Wall.|pdf=|usr=}}{{33917965}}
{{tp|p=33632150|t=2021. Low plasma magnesium concentration and future abdominal aortic calcifications in moderate chronic kidney disease.|pdf=|usr=}}{{33632150}}
{{tp|p=29478069|t=2018. Magnesium in Chronic Kidney Disease: Should We Care?|pdf=|usr=}}{{29478069}}
{{ttp|p=28645983|t=2017. The effect of magnesium supplementation on vascular calcification in chronic kidney disease-a randomised clinical trial (MAGiCAL-CKD): essential study design and rationale.|pdf=|usr=}}{{28645983}}
{{tp|p=28385153|t=2017. Lower serum magnesium is associated with vascular calcification in peritoneal dialysis patients: a cross sectional study.|pdf=|usr=}}{{28385153}}
{{tp|p=27771720|t=2016. Dietary Magnesium and Kidney Function Decline: The Healthy Aging in Neighborhoods of Diversity across the Life Span Study.|pdf=|usr=}}{{27771720}}
{{tp|p=27419135|t=2016. Magnesium Attenuates Phosphate-Induced Deregulation of a MicroRNA Signature and Prevents Modulation of Smad1 and Osterix during the Course of Vascular Calcification.|pdf=|usr=}}{{27419135}}
{{tp|p=23506202|t=2014. Phosphate: an old bone molecule but new cardiovascular risk factor.|pdf=|usr=}}{{23506202}}
{{tp|p=38222032|t=2024. Similarities and Differences of Vascular Calcification in Diabetes and Chronic Kidney Disease.|pdf=|usr=}}{{38222032}}
{{tp|p=37915933|t=2023. Hypomagnesemia: a potential underlooked cause of persistent vitamin D deficiency in chronic kidney disease.|pdf=|usr=}}{{37915933}}
{{tp|p=36388921|t=2022. The role of extracellular vesicles in vascular calcification in chronic kidney disease.|pdf=|usr=}}{{36388921}}
{{tp|p=35453928|t=2022. Magnesium-A More Important Role in CKD-MBD than We Thought.|pdf=|usr=}}{{35453928}}
{{tp|p=34901204|t=2021. IL-18 Mediates Vascular Calcification Induced by High-Fat Diet in Rats With Chronic Renal Failure.|pdf=|usr=}}{{34901204}}
{{ttp|p=34689162|t=2021. Deletion of soluble epoxide hydrolase suppressed chronic kidney disease-related vascular calcification by restoring Sirtuin 3 expression.|pdf=|usr=}}{{34689162}}
{{tp|p=34504876|t=2021. beta-Hydroxybutyric Inhibits Vascular Calcification via Autophagy Enhancement in Models Induced by High Phosphate.|pdf=|usr=}}{{34504876}}
{{ttp|p=33282857|t=2020. The Role of Disturbed Mg Homeostasis in Chronic Kidney Disease Comorbidities.|pdf=|usr=}}{{33282857}}
{{tp|p=30887097|t=2019. Signaling pathways involved in vascular smooth muscle cell calcification during hyperphosphatemia.|pdf=|usr=}}{{30887097}}
{{tp|p=25852855|t=2014. Magnesium: a renewed player of vascular ageing in diabetic CKD patients?|pdf=|usr=}}{{25852855}}
{{tp|p=26069821|t=2012. Magnesium and outcomes in patients with chronic kidney disease: focus on vascular calcification, atherosclerosis and survival.|pdf=|usr=}}{{26069821}}
{{ttp|p=35232774|t=2022. Interventions To Attenuate Vascular Calcification Progression in Chronic Kidney Disease: A Systematic Review of Clinical Trials.|pdf=|usr=}}{{35232774}}
{{tp|p=34793336|t=2022. SIRT6 protects vascular smooth muscle cells from osteogenic transdifferentiation via Runx2 in chronic kidney disease.|pdf=|usr=}}{{34793336}}
{{tp|p=34003800|t=2021. ALKBH1-demethylated DNA N6-methyladenine modification triggers vascular calcification via osteogenic reprogramming in chronic kidney disease.|pdf=|usr=}}{{34003800}}
{{tp|p=33369187|t=2021. Role of gut microbiota-derived metabolites on vascular calcification in CKD.|pdf=|usr=}}{{33369187}}
{{tp|p=35330975|t=2021. Kv1.3 Channel Inhibition Limits Uremia-Induced Calcification in Mouse and Human Vascular Smooth Muscle.|pdf=|usr=}}{{35330975}}
{{tp|p=31036759|t=2019. A Randomized Trial of Magnesium Oxide and Oral Carbon Adsorbent for Coronary Artery Calcification in Predialysis CKD.|pdf=|usr=}}{{31036759}}
{{tp|p=30977017|t=2019. Hypomagnesemia is not an independent risk factor for mortality in Japanese maintenance hemodialysis patients.|pdf=|usr=}}{{30977017}}
{{tp|p=30826804|t=2019. Low serum magnesium is associated with faster decline in kidney function: the Dallas Heart Study experience.|pdf=|usr=}}{{30826804}}
{{tp|p=29495444|t=2018. Magnesium Replacement to Protect Cardiovascular and Kidney Damage? Lack of Prospective Clinical Trials.|pdf=|usr=}}{{29495444}}
{{tp|p=26885127|t=2015. Proton pump inhibitors use in hemodialysis patients and serum magnesium levels.|pdf=|usr=}}{{26885127}}
{{tp|p=26089881|t=2015. Low Magnesium Levels and FGF-23 Dysregulation Predict Mitral Valve Calcification as well as Intima Media Thickness in Predialysis Diabetic Patients.|pdf=|usr=}}{{26089881}}
{{tp|p=35134986|t=2022. Dietary magnesium supplementation inhibits abdominal vascular calcification in an experimental animal model of chronic kidney disease.|pdf=|usr=}}{{35134986}}
{{ttp|p=33851114|t=2021. Serum Magnesium and Cardiovascular Outcomes and Mortality in CKD: The Chronic Renal Insufficiency Cohort (CRIC).|pdf=|usr=}}{{33851114}}
{{tp|p=33851109|t=2021. Magnesium and Cardiovascular Disease in CKD: The Mysteries of a Humble Divalent Cation.|pdf=|usr=}}{{33851109}}
{{tp|p=33481059|t=2021. Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approaches.|pdf=|usr=}}{{33481059}}
{{tp|p=33374019|t=2022. Magnesium to prevent kidney disease-associated vascular calcification: crystal clear?|pdf=|usr=}}{{33374019}}
{{tp|p=32494818|t=2020. Low serum magnesium as a risk factor for peripheral artery disease in chronic kidney disease: an open verdict.|pdf=|usr=}}{{32494818}}
{{tp|p=31194171|t=2019. Diabetes Mellitus Modifies the Associations of Serum Magnesium Concentration With Arterial Calcification and Stiffness in Incident Hemodialysis Patients.|pdf=|usr=}}{{31194171}}
{{tp|p=29704284|t=2018. Prognostic importance of plasma total magnesium in a cohort of cats with azotemic chronic kidney disease.|pdf=|usr=}}{{29704284}}
{{tp|p=29142966|t=2017. Oral Magnesium Supplementation in Chronic Kidney Disease Stages 3 and 4: Efficacy, Safety, and Effect on Serum Calcification Propensity-A Prospective Randomized Double-Blinded Placebo-Controlled Clinical Trial.|pdf=|usr=}}{{29142966}}
{{tp|p=25272232|t=2015. Results from the Atherosclerosis Risk in Communities study suggest that low serum magnesium is associated with incident kidney disease.|pdf=|usr=}}{{25272232}}
{{tp|p=25227765|t=2015. Magnesium in CKD: more than a calcification inhibitor?|pdf=|usr=}}{{25227765}}
{{ttp|p=23486515|t=2013. Effect of a magnesium-based phosphate binder on medial calcification in a rat model of uremia.|pdf=|usr=}}{{23486515}}
{{tp|p=34143857|t=2021. Association between serum magnesium levels and abdominal aorta calcification in patients with pre-dialysis chronic kidney disease stage 5.|pdf=|usr=}}{{34143857}}
{{tp|p=33003628|t=2020. Uremic Toxins and Vascular Calcification-Missing the Forest for All the Trees.|pdf=|usr=}}{{33003628}}
{{tp|p=30813254|t=2019. Magnesium: A Magic Bullet for Cardiovascular Disease in Chronic Kidney Disease?|pdf=|usr=}}{{30813254}}
{{tp|p=28178182|t=2017. Effects of Magnesium on the Phosphate Toxicity in Chronic Kidney Disease: Time for Intervention Studies.|pdf=|usr=}}{{28178182}}
{{tp|p=27023783|t=2016. Hypomagnesemia Is Associated with Increased Mortality among Peritoneal Dialysis Patients.|pdf=|usr=}}{{27023783}}
{{ttp|p=25545498|t=2014. Magnesium modifies the cardiovascular mortality risk associated with hyperphosphatemia in patients undergoing hemodialysis: a cohort study.|pdf=|usr=}}{{25545498}}
{{ttp|p=38092856|t=2023. Lower product of magnesium x potassium is associated with higher mortality in chronic hemodialysis patients: a cohort study.|pdf=|usr=}}{{38092856}}
{{ttp|p=36699036|t=2022. Fibroblast growth factor 23 is independently associated with renal magnesium handling in patients with chronic kidney disease.|pdf=|usr=}}{{36699036}}
{{tp|p=34584906|t=2021. Diurnal variation of magnesium and the mineral metabolism in patients with chronic kidney disease.|pdf=|usr=}}{{34584906}}
{{tp|p=34322504|t=2021. The Association Between Exposure to Low Magnesium Blood Levels After Renal Transplantation and Cardiovascular Morbidity and Mortality.|pdf=|usr=}}{{34322504}}
{{tp|p=33614731|t=2021. Prognostic Value of Serum Magnesium in Mortality Risk among Patients on Hemodialysis: A Meta-Analysis of Observational Studies.|pdf=|usr=}}{{33614731}}
{{tp|p=33159963|t=2021. Targeting fibroblast growth factor 23-responsive pathways uncovers controlling genes in kidney mineral metabolism.|pdf=|usr=}}{{33159963}}
{{tp|p=32494148|t=2020. Vascular Calcification: An Important Understanding in Nephrology.|pdf=|usr=}}{{32494148}}
{{tp|p=32066594|t=2020. Electrolyte Disorders in Kidney Transplantation.|pdf=|usr=}}{{32066594}}
{{tp|p=30430111|t=2018. Nutrition Trends in Kidney Transplant Recipients: the Importance of Dietary Monitoring and Need for Evidence-Based Recommendations.|pdf=|usr=}}{{30430111}}
{{tp|p=30333977|t=2018. Electrolyte and Acid-Base Disorders in the Renal Transplant Recipient.|pdf=|usr=}}{{30333977}}
{{tp|p=29969455|t=2018. Proton pump inhibitor as an independent factor of progression of abdominal aortic calcification in patients on maintenance hemodialysis.|pdf=|usr=}}{{29969455}}
{{tp|p=29799851|t=2018. Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease.|pdf=|usr=}}{{29799851}}
{{tp|p=29725641|t=2018. Proton Pump Inhibitor Usage and the Risk of Mortality in Hemodialysis Patients.|pdf=|usr=}}{{29725641}}
{{tp|p=24944752|t=2014. Are there ways to attenuate arterial calcification and improve cardiovascular outcomes in chronic kidney disease?|pdf=|usr=}}{{24944752}}
{{tp|p=24255887|t=2013. Lowering vascular calcification burden in chronic kidney disease: Is it possible?|pdf=|usr=}}{{24255887}}
{{tp|p=24175241|t=2012. Vascular calcification in chronic kidney disease: Pathogenesis and clinical implication.|pdf=|usr=}}{{24175241}}
{{tp|p=26069820|t=2012. Magnesium in chronic kidney disease Stages 3 and 4 and in dialysis patients.|pdf=|usr=}}{{26069820}}
{{tp|p=31036759|t=2019. A Randomized Trial of Magnesium Oxide and Oral Carbon Adsorbent for Coronary Artery Calcification in Predialysis CKD.|pdf=|usr=}}{{31036759}}
{{tp|p=37441489|t=2023. Reduced Levels of the Antiaging Hormone Klotho are Associated With Increased Aortic Stiffness in Diabetic Kidney Disease.|pdf=|usr=}}{{37441489}}